
10-13 July 2026
A quieter post holiday week, but with one major sale and one substantial raise. Resmed sold off their MatrixCare post-acute software business to private equity, for substantially less than they paid for it seven years ago. The big raise was Pearl Health’s. Not so pearly were the substantial sentences and fines given to Done Health’s principals for out of control Adderall prescribing and fraud. Nor was 23andMe’s data breach settlement of $47 million while still in bankruptcy, or another Oracle software vulnerability. And OpenAI’s offer of 5% to the US government–good deal or Trojan Horse? But there’s hope in the 26th clinical trial of Elon Musk’s Neuralink in a Canadian ALS patient.
Please feel free to comment on the articles and pass along this Alert. Let me know if this is worth it to you! Also check out my personal page on Substack.
Recent Headlines, from Midjourney Medical scanning to Cargo Culture
Perspectives: The most aggressive AI adoption in healthcare is happening off the books
* * *
Advertise on Telehealth and Telecare Aware
Support not only a publication but also a well-informed international community.
Contact Editor Donna for more information.
Help Spread the News
Please tell your colleagues about this free news service and, if you have relevant information to share with the rest of the world, please let me know!
Donna Cusano, Editor In Chief
donna.cusano@telecareaware.com
Telehealth & Telecare Aware – covering news on latest developments in telecare, telehealth and eHealth, worldwide.
To leave the email alerts mailing list either use the ‘Unsubscribe Here’ link at the bottom of this email (if you can see it) or email Editor Donna.







Leave a Reply